Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
about
Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011).Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancerPredict the Future Incidence and Mortality of Breast Cancer in Iran from 2012-2035.Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers.Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.E2F4 regulatory program predicts patient survival prognosis in breast cancer.Prognostic Factors in Operated Stage IIIC, Pathological N3a Breast Cancer Patients.Quantum dots-based quantitative and in situ multiple imaging on ki67 and cytokeratin to improve ki67 assessment in breast cancer.Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer.Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based studyBreast Cancer in Elderly Caucasian Women-An Institution-Based Study of Correlation between Breast Cancer Prognostic Markers, TNM Stage, and Overall Survival.Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort studyKi-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registryEpidemiology and prognosis of breast cancer in young womenThe expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancerDecreased expression of the CHD5 gene and its clinicopathological significance in breast cancer: Correlation with aberrant DNA methylation.Role of TGF-β in breast cancer bone metastases.Outcomes in Patients with pT1-T2, pN0-N1 Breast Cancer After Conservative Surgery and Whole-breast Radiotherapy.Prognostic value of survivin expression in breast cancer patients: a meta-analysis.MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation.Trends in breast cancer in the elderly in Denmark, 1980-2012.Nuclear grade plus proliferation grading system for invasive ductal carcinoma of the breast: validation in a tertiary referral hospital cohort.Age-related socio-economic and geographic disparities in breast cancer stage at diagnosis: a population-based study.CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.Basal ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer.Prognostic factors of survival in pathologic incomplete response patients with locally advanced breast cancer after neoadjuvant chemotherapy.Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.Relative and disease-free survival for breast cancer in relation to subtype: a population-based study.Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer.
P2860
Q30813968-476A016D-4446-4687-BFC0-7F6B2155D8F5Q33699104-F76093DF-6353-4248-91BF-18E38C015A77Q33711146-B284EC62-4DFF-47CF-8B07-048589D2DF46Q33757796-715EC910-9145-42AD-9B2E-761C339FE5E5Q34371241-34FAAC36-F353-4A0B-8230-934C37397BE8Q35000629-040988B1-D11B-46A9-9788-08B81A12506FQ35050980-54450578-4CCA-4C83-90C9-3193E3B8918AQ35347732-8FAA6FB0-8F33-427C-81E9-1D5FB28D13DBQ35790197-390ED140-77C8-4300-9ECF-DB775D365258Q35944405-3FCF1AAF-F0F5-4DD9-895C-E24BC97A0925Q36102834-AA7B0F7F-AE6F-412B-8E3E-F9D5FDF3120CQ36135274-F709C214-4B92-4345-816B-5F4E572F8640Q36892788-3EB0DF97-CD53-4BDD-9860-77583273BD63Q36963366-49263F55-0E04-43B9-8C36-F4C45BEE6529Q37122778-A677ED4A-5BF7-4465-8158-CAAD48F87FBAQ37407277-484B7138-4213-4869-8FA3-D8A37DD88FB4Q37591417-BCEC87D8-FDE5-4DEA-BB43-34222CEE7992Q37705288-A7DCCAD6-400B-4055-8CC3-8C1FDA358899Q38108262-25A9241B-26B7-443B-A734-B0F82AB121C0Q39022633-297E939D-A169-4AA9-8E3E-A26C791A1255Q40093517-1872B119-D0DE-4866-B70F-80337DAEA56BQ41120614-C37EAFAA-A0B9-415F-A728-585A6B2F060DQ41130887-DE09B014-82C8-42BF-BDD7-AAED40E0AE76Q41235139-39B7B5F1-882D-416C-86F4-FE89B2168C9CQ41562136-A7344F60-8219-4A14-B4F4-52318A4A900EQ42479479-FC639150-78AC-4B41-B60E-D298FD25B4BDQ43522921-452D11F7-C7BA-44C7-A953-C8045919C354Q44490673-5E66B06F-171C-4C11-A44F-23A8EBE3331FQ46558451-BEABDF34-6920-4E50-9530-0B11DC46F985Q52936770-FC3F17EA-F52E-4A02-98AC-21C9966F2D21
P2860
Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prognostic value of breast can ...... r survival in Caucasian women.
@en
Prognostic value of breast can ...... r survival in Caucasian women.
@nl
type
label
Prognostic value of breast can ...... r survival in Caucasian women.
@en
Prognostic value of breast can ...... r survival in Caucasian women.
@nl
prefLabel
Prognostic value of breast can ...... r survival in Caucasian women.
@en
Prognostic value of breast can ...... r survival in Caucasian women.
@nl
P2093
P2860
P356
P1433
P1476
Prognostic value of breast can ...... r survival in Caucasian women.
@en
P2093
Amila Orucevic
Barbara Munsey
Lisa Duncan
N Lynn Ferguson
Robert Heidel
Solomon Lee
Stuart Vanmeter
Timothy Panella
P2860
P356
10.1111/TBJ.12059
P577
2012-12-13T00:00:00Z